$CNSP
CNS Pharmaceuticals, Inc.
Nasdaq · Healthcare · Pharmaceutical Preparations · Houston, TX
CNSP chart
What traders are saying about $CNSP
Latest postsCNS Pharmaceuticals, Inc. news
- CNS Pharmaceuticals, Inc. Estimates – NASDAQ:CNSP
TradingView ·
- CNS Pharmaceuticals Details Business Development Strategy Driving Its Next Phase of Growth
Yahoo Finance ·
- CNS Pharmaceuticals Participates in the Virtual Investor "Why Now" On-Demand Conference
Yahoo Finance ·
- CNS Pharmaceuticals Reports Second Quarter 2026 Results, Highlighting Strengthened Balance Sheet and Accelerated Execution of Strategic Transformation
Yahoo Finance ·
- CNS Pharmaceuticals CFO, Steve O'Loughlin, Highlights Company's Recent $22.5M Financing in Virtual Investor "What This Means" Segment
Yahoo Finance ·
- CNS Pharmaceuticals CEO, Rami Levin, Participates in Virtual Investor CEO Connect Segment Highlighting Company's Recent Strategic Transformation Progress
Yahoo Finance ·
- Forget the 242% Biotech Meme. This Brain Cancer Stock Has a $38 Analyst Target and Trades at $6
247wallst.com ·
- CNS Pharmaceuticals Reports First Quarter 2026 Financial Results and Highlights Strategic Transformation Progress
Yahoo Finance ·
- Top Midday Gainers
Yahoo Finance ·
- CNS Pharmaceuticals Announces Oversubscribed $22.5 Million Private Placement Financing
Yahoo Finance ·
- CNS Pharmaceuticals Launches New Corporate Strategy Focused on Building a High-Value Neurology and Oncology Pipeline
Yahoo Finance ·
- CNS Pharmaceuticals Appoints Multiple Key Executives to Drive Company's Recently Initiated Strategic Transformation
Yahoo Finance ·
CNS Pharmaceuticals, Inc. key financials
| USD | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|
| Net income | -$15,987 | -$14,858 | -$18,851 | -$15.3M |
| Diluted EPS | $-35.75 | $-466.89 | $-12509.11 | $-11.22 |
| Total assets (year end) | $8.6M | $8.7M | $1.7M | $13.1M |
| Cash and equivalents (year end) | $7.2M | $6.5M | $548,721 | $10.1M |
Calendar-year figures as reported to the SEC in XBRL filings.
Recent SEC filings
About CNS Pharmaceuticals, Inc.
- Ticker
- CNSP (Nasdaq)
- Industry
- Pharmaceutical Preparations
- Headquarters
- Houston, TX
- Incorporated in
- NV
- Fiscal year end
- December 31
- SEC CIK
- 1729427
Frequently asked questions
What exchange is CNS Pharmaceuticals, Inc. listed on?
CNS Pharmaceuticals, Inc. trades on the Nasdaq under the ticker symbol CNSP.
What industry is CNS Pharmaceuticals, Inc. in?
CNS Pharmaceuticals, Inc. is classified by the SEC under "Pharmaceutical Preparations", part of the Healthcare sector on StockTweeting.
Where is CNS Pharmaceuticals, Inc. headquartered?
CNS Pharmaceuticals, Inc.'s business address on file with the SEC is in Houston, TX.
When does CNS Pharmaceuticals, Inc.'s fiscal year end?
CNS Pharmaceuticals, Inc.'s fiscal year ends on December 31.